Example: Heart Attack

Clinical Trials on Peripheral Nervous System Neoplasms

Total 498 results

NCT02986919

Withdrawn

Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors

Conditions: Peripheral Nerve Tumors
NCT03109301

Withdrawn

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

Conditions: Neoplasms, Nerve Tissue; Neurofibromatosis 1; Heredodegenerative Disorders, Nervous System; Peripheral Nervous System Diseases
NCT03231306

Active, not recruiting

Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas

Conditions: Neurofibromatosis Type 1; Plexiform Neurofibroma
NCT03141021

Recruiting

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

Conditions: Malignant Peripheral Nerve Sheath Tumors
NCT02691026

Recruiting

A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery

Conditions: Malignant Peripheral Nerve Sheath Tumour (MPNST)
NCT00427583

Terminated

Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

Conditions: Malignant Peripheral Nerve Sheath Tumors
NCT02492360

Withdrawn

Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy

Conditions: Peripheral Nervous System Diseases; Testicular Neoplasms
NCT02584647

Recruiting

PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

Conditions: Sarcoma; Malignant Peripheral Nerve Sheath Tumors
NCT02008877

Completed

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

Conditions: Malignant Peripheral Nerve Sheath Tumors (MPNST); Sarcoma
NCT03433183

Recruiting

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

Conditions: Malignant Peripheral Nerve Sheath Tumors; Neurofibromatosis 1
NCT02700230

Recruiting

Vaccine Therapy in Treating Patients With Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery

Conditions: Metastatic Malignant Peripheral Nerve Sheath Tumor; Neurofibromatosis Type 1; Recurrent Malignant Peripheral Nerve Sheath Tumor
NCT04465643

Not yet recruiting

Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor

Conditions: Nerve Sheath Tumors
NCT01661283

Completed

SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors

Conditions: Malignant Peripheral Nerve Sheath Tumors; MPNST; Sarcoma
NCT03872427

Recruiting

Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study

Conditions: Advanced Malignant Solid Neoplasm; Metastatic Malignant Solid Neoplasm; NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor; Unresectable Malignant Solid Neoplasm
NCT02452554

Active, not recruiting

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

Conditions: Pleuropulmonary Blastoma; Recurrent Malignant Peripheral Nerve Sheath Tumor; Recurrent Neuroblastoma; Recurrent Rhabdomyosarcoma; Recurrent Synovial Sarcoma; Wilms Tumor
NCT03332030

Suspended

Stem Cells in NF1 Patients With Tumors of the Central Nervous System

Conditions: Neurofibromatosis Type 1; Tumors of the Central Nervous System
NCT00003211

Completed

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor

Conditions: Brain and Central Nervous System Tumors
NCT00007982

Completed

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

Conditions: Brain and Central Nervous System Tumors; Head and Neck Cancer; Lymphoma
NCT04222413

Recruiting

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Conditions: Advanced Solid Tumors; Metastatic Pancreatic Cancer; Pediatric Solid Tumor; Advanced Breast Cancer; Malignant Peripheral Nerve Sheath Tumor
NCT01218139

Unknown status

Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients

Conditions: Neurofibromatosis Type 1
NCT02211768

Completed

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Conditions: Neurofibromatosis; MPNST
NCT00869804

Terminated

Heading Off Peripheral Neuropathy With Exercise

Conditions: Peripheral Nervous System Disorders; Breast Neoplasms; Chemotherapy
NCT00068367

Completed

S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor

Conditions: Sarcoma
NCT00003846

Completed

Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors

Conditions: Brain and Central Nervous System Tumors; Neuroblastoma
NCT00304083

Completed

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

Conditions: Neurofibromatosis Type 1; Sarcoma